Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-05-05 | Dr. Braun has served as a director of the Company since December 2015. Dr. Braun brings over 30 years of research expertise in oncology, with a focus on immunotherapy and the effectiveness and impact of chemotherapy protocols on various cancers and tumor types, and served from 2006 to 2014 as Vice President Clinical Research and since 2014 as Vice President Translational Research and Chief Science Officer at the Cancer Treatment Centers of America. He received his Ph.D. in Immunology and Microbiology from the University of Illinois at the Medical Center in Chicago. |
| 2018-03-30 | Dr. Braun received his Ph.D. in Immunology and Microbiology from the University of Illinois at the Medical Center in Chicago. |
| 2019-03-29 | Dr. Braun brings over 30 years of research expertise in oncology, with a focus on immunotherapy and the effectiveness and impact of chemotherapy protocols on various cancers and tumor types and served from 2006 to 2014 as Vice President Clinical Research and since 2014 as Vice President Translational Research and Chief Science Officer at the Cancer Treatment Centers of America. He received his Ph.D. in Immunology and Microbiology from the University of Illinois at the Medical Center in Chicago. |
| 2020-04-29 | Dr. Braun has been appointed to and served on more than a dozen federal government and public advisory committees on oncology and immunology. He received his Ph.D. in Immunology and Microbiology from the University of Illinois at the Medical Center in Chicago. |
| 2021-04-20 | Dr. Donald P. Braun received his Ph.D. in Immunology and Microbiology from the University of Illinois at the Medical Center in Chicago. |
| 2022-01-25 | Donald P. Braun* (14) 119,908 shares of Common Stock beneficially owned. |
| 2022-04-29 | Dr. Braun has over 35 years of research experience in oncology, cancer immunology, cancer immunotherapy, and inflammatory diseases. He received his Ph.D. in Immunology and Microbiology from the University of Illinois at the Medical Center in Chicago. Dr. Braun has served as an advisor to numerous public agencies and private corporations concerned with cancer therapeutics and diagnostics including Pfizer Pharmaceuticals, Sterling Winthrop, Abbott Laboratories, Boehringer Mannheim, Serono Corporation, Biomira Inc, Centocor and Merck KGA. |
Data sourced from SEC filings. Last updated: 2025-07-01